GeorgiaState Snapshot for Children
In this comparison, the NHQDR measures for Georgia for the most recent data year and the baseline year are compared to the average of all States.
Historically, the State Snapshots have included State-specific estimates for selected AHRQ Quality Indicators (QIs) based on Healthcare Cost and Utilization Project (HCUP) data. The 2018 QDR does not include State-specific QI estimates based on 2016 HCUP data because the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System version of the QI software used did not include risk adjustment. State-specific QIs will be reported in future QDRs when the estimates can be risk adjusted.
|Measure||Population||Recent Year||Recent Rate||Recent Performance||Baseline Year||Baseline Rate||Baseline Performance|
|Children ages 19-35 months who received 3 or more doses of polio vaccine||Total||2016||97.0||Better than Average||2000||92.2||Average|
|Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine||Total||2016||93.1||Better than Average||2008||44.2||Average|
|Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine||Total||2016||90.0||Better than Average||2000||84.4||Average|
|Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine||Total||2016||95.5||Better than Average||2000||92.5||Average|
|Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years||Total||2016||94.5||Better than Average||2008||28.2||Average|